abnormal blood cell morphology/development_Tg(Vav1-JAK2*V617F)AZjz/0

http://metadb.riken.jp/0002429IC57BL6DBA2TgVav1JAK2V617FAZjz0TgVav1JAK2V617FAZjz

abnormal blood cell morphology/development_Tg(Vav1-JAK2*V617F)AZjz/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion A, Zhizhuang Joe Zhao
  http://metadb.riken.jp/db/mgi_rdf/MGI:5441305

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Vav1-JAK2*V617F)AZjz/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Vav1-JAK2*V617F)AZjz

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * DBA/2

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal blood cell morphology/development
  http://purl.obolibrary.org/obo/MP_0002429

文献

http://purl.org/net/cito/citesAsAuthority

• Shu. Xing, et.al., Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice., Blood, 2008, 111
  http://rdf.ncbi.nlm.nih.gov/pubmed/18334677